The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...
According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...
Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump- Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA / ACCESS Newswire / November ...
When a child is diagnosed with diabetes, it can feel overwhelming for parents, as everyday routines suddenly revolve around ...
MannKind's stock has gained momentum amid optimism over its expanding diabetes portfolio and 2026 milestones. CEO Michael Castagna said the FDA has accepted its Afrezza pediatric application, ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
On Sunday in Chicago, Dr. Athena Philis-Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin ...
Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump- Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA / ...
Abstract: Managing blood glucose levels through multiple daily injections (MDIs) of insulin presents a challenge in daily diabetes care, necessitating frequent self-dosing adjustments to avoid ...
Glooko Inc. and Hedia ApS launched an integrated software solution in the U.K. to support people with diabetes who require advanced doses of bolus insulin. The solution combines Glooko’s diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback